戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 180作成日:2026年10月23日

2-[2-Chloro-5-(trifluoromethyl)pyridin-4-ylamino]-N-methylbenzamide → N-methyl-2-[[2-[[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]amino]-5-(trifluoromethyl)pyridin-4-yl]amino]benzamide

https://huagongshe.com/ja/reaction/180

反応式

関与物質

役割名称HCID仕込み量
反応物2-[2-Chloro-5-(trifluoromethyl)pyridin-4-ylamino]-N-methylbenzamideHCID 56655328—
反応物1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-amine hydrochlorideHCID 75480753—
試薬Cesium carbonateHCID 10796—
触媒1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
触媒Palladium (II) acetateHCID 4144353—
溶媒1,4-DioxaneHCID 31275—
生成物N-methyl-2-[[2-[[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]amino]-5-(trifluoromethyl)pyridin-4-yl]amino]benzamideHCID 8725962360.42%

反応条件

温度100 °C

反応手順

2-(2-chloro-5-(trifluoromethyl)pyridin-4-ylamino)-N-methylbenzamide (100 mg, 0.30 mmol), 1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-amine hydrochloride (122 mg, 0.61 mmol), cesium carbonate (247 mg, 0.76 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (28.1 mg, 0.05 mmol) and diacetoxypalladium (5.45 mg, 0.02 mmol) were suspended in dioxane (1.5 mL) and sealed into a tube. The reaction was degased, purged with nitrogen and heated to 100 °C for 18 hours. Reaction was filtered. The reaction mixture was purified by preparative HPLC using a Waters X-Bridge reverse-phase column (C-18, 5 microns silica, 19 mm diameter, 100 mm length, flow rate of 40 ml / minute) and decreasingly polar mixtures of water (containing 0.2% ammonium carbonate) and acetonitrile as eluent. The fractions containing the desired compound were evaporated to dryness to afford N-methyl-2-(2-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-ylamino)-5-(trifluoromethyl)pyridin-4-ylamino)benzamide (84 mg, 60.4 %) as a yellow crystalline solid.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-db51fb4c9ca342c3a64870763aaddcf0
出典メモ750 AstraZeneca ELN dataset